J. De Wet
1 Papers
36 Citations
J. De Wet is an academic researcher. The author has contributed to research in topics: Viral load & Hepatitis C. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials
Mark T. Nelson,Gerardo Amaya,Nathan Clumeck,Clovis Arns da Cunha,Dushyantha Jayaweera,Patrice Junod,Taisheng Li,Pablo Tebas,Marita Stevens,Annemie Buelens,Simon Vanveggel,Katia Boven,L. Abusamra,P. Cahn,H. E. Laplume,Isabel Cassetti,Mariana Ceriotto,Marcelo Martins,Alejandro J. Krolewiecki,L. Amarilis Lugo,Robert K. Bolan,Bush Lm,R. Corales,Lawrence R. Crane,J. de Vente,Margaret A. Fischl,J. Gathe,R. Greenberg,Keith Henry,D. Jayaweera,Princy Kumar,J. Lalezari,J. Leider,R. Lubelchek,Claudia Martorell,Karam Mounzer,C Cohen,H. Olivet,Roberto Ortiz,Frank S. Rhame,Afsoon D. Roberts,Peter Ruane,A. Scribner,Sorana Segal-Maurer,W. Short,Louis Sloan,Timothy J. Wilkin,M. Wohlfeiler,B. Yangco,Mark Bloch,Julian Gold,Jennifer F Hoy,Martínez P,D. Baker,Robert Finlayson,Norman Roth,Armin Rieger,N. Vetter,Robert Zangerle,C. A. Da Cunha,Beatriz Grinsztejn,José Valdez Madruga,José Henrique Pilotto,D. Sampaio,C. R. Gonsalez,M. P. Lima,F. Rangel,A. Timerman,P. Junod,D. Kilby,Anita Rachlis,Sharon Walmsley,M. Boissonnault,Jason Brunetta,J. De Wet,John Gill,K. Kasper,John Macleod,Jan Gerstoft,Lars Mathiesen,Christian N. S. Pedersen,Laurent Cotte,P M Girard,J.-M. Molina,F Raffi,Daniel Vittecoq,Yazdan Yazdanpanah,Patrick Yeni,François Boué,Christine Katlama,Jacques Reynes,Martin Fisher,Mark Nelson,Chloe Orkin,Stephen Taylor,Margaret A. Johnson,Edmund Wilkins,Ian Williams,Alan Winston,Adriano Lazzarin,Pasquale Narciso,Anna Orani,Stefano Rusconi,Andrea Antinori,G. Carosi,Francesco Mazzotta,G. Amaya,Gustavo Reyes-Teran,Jaime Andrade-Villanueva,J. G. Sierra Madero,Bart J. A. Rijnders,Jorge Santana,Carmen D. Zorrilla,F Antunes,T. Branco,R. Sarmento,E. Castro,T. Eugenio,Kamal Mansinho,R. Marques,D. Duiculescu,L. Negrutiu,Liviu-Jany Prisacariu,Valeriy Viktorovich Kulagin,Evgeniy Voronin,A. Yakovlev,N. Dushkina,A. Pronin,O. Tsibakova,E. Vinogradova,E. Baraldi,N. David,O. Ebrahim,E. Krantz,G. H. Latiff,D. Spencer,Robin Wood,Mariette E. Botes,Francesca Conradie,Jan Fourie,Lerato Mohapi,D. Petit,D. Steyn,Jose R. Arribas,J. Portilla Sogorb,Esteban Ribera,I. Santos Gil,B Clotet,Félix Gutiérrez,Daniel Podzamczer,Vincent Soriano,Katarina Westling,Ploenchan Chetchotisakd,Thira Sirisanthana,Somnuek Sungkanuparph,Asda Vibhagool,Kiat Ruxrungtham,W. Techasathit,Chien-Ching Hung,H. C. Lee,H. H. Lin,W. W. Wong,H. Albrecht,Nicholas Bellos,Daniel S Berger,Cynthia Brinson,B. Casanas,Richard Elion,Judith Feinberg,T. File,Jason Flamm,Charles B. Hicks,Sally Hodder,C. B. Hsiao,P. Kadlecik,Homayoon Khanlou,Kinder Ca,Ralph Liporace,Cynthia Mayer,Donna Mildvan,Anthony Mills,Robert A. Myers,I. Nadeem,Olayemi Osiyemi,Michael F. Para,Gerald Pierone,B. Rashbaum,Juan Carlos Rodríguez,Michael S. Saag,James H. Sampson,Rafik Samuel,Michael Sension,P. Shalit,P. Tebas,William J. Towner,Aimee M. Wilkin,J. J. Eron,David A. Wohl,Robert Colebunders,Nathan Clumeck,Jean-Christophe Goffard,F. Van Wanzeele,E. Van Wijngaerden,J. Ballesteros,R. Northland,Carlos Perez,L. Hongzhou,T. Li,W. Cai,Hulin Wu,X. Li,G. Herrera,Keikawus Arastéh,Stefan Esser,Gerd Fätkenheuer,Thomas A. Lutz,Reinhold E. Schmidt,D. Schuster,Hans-Jürgen Stellbrink,N. Kumarasamy,P. Patil,A. Canton Martinez,A. Rodriguez-French,N. Sosa +223 more
TL;DR: Hematic AEs were more common and response rates lower in HBV/HCV-coinfected patients treated with rilpivirine or efavirenz than in those who were not coinfected and the incidence of hepatic adverse events (AEs) was low in both groups in the overall population.